Such an effect likely occurs through interactions with other protein targets, a scenario that is linked to the IDP properties of Spd1, allowing for multi-valency during interactions [29]. But what is this other target of Spd1? Human p21 is a CRL4Cdt2-targeted IDP that can inhibit ...